Serum creatinine as an indicator of lean body mass in vegetarians and omnivores.
Eric Bartholomae, Jessica Knurick, Carol S Johnston
https://pubmed.ncbi.nlm.nih.gov/36185683/Actively Recruiting
Led by University Hospital Ostrava · Updated on 2026-02-05
492
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are studying whether low serum creatinine levels at admission to a post-ICU care unit can predict the need for longer ventilatory support in critically ill adults. The study also explores if giving creatine supplements to patients with low creatinine levels can shorten the time they need ventilators and improve their overall outcomes. This research addresses muscle loss and its effects after a critical illness stay in the ICU. The study includes three groups of adult patients admitted to a post-ICU care unit. One group with normal creatinine levels will receive standard care without any intervention. Patients with low creatinine levels will be randomly assigned to receive either creatine supplements or a placebo, both given orally or via a tube for up to 21 days. The creatine dosage is 10 grams daily for the first 7 days and 5 grams daily from days 8 to 21. Participants will be monitored for 21 days to track ventilator-free hours, infections, muscle strength, cognitive status, and ability to care for themselves. The study will assess tolerance to creatine and compare outcomes between groups. Careful observation and data collection will help determine the relationship between creatinine levels, creatine supplementation, and weaning from mechanical ventilation.
CONDITIONS
Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
J
Jiří Hynčica
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital Ostrava
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Up to 21 days
Participants with subnormal baseline serum creatinine receive dietary supplements of creatine or placebo for up to 21 days. Participants with normal creatinine receive standard care without intervention.
Daily administration during first 7 days and daily administration from days 8 to 21; visit schedule may vary according to care needs
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Eric Bartholomae, Jessica Knurick, Carol S Johnston
https://pubmed.ncbi.nlm.nih.gov/36185683/Felix Klawitter, Johannes Ehler, Rika Bajorat...
https://pubmed.ncbi.nlm.nih.gov/36982590/Sun-wook Kim, Hee-Won Jung, Cheol-Ho Kim...
https://pubmed.ncbi.nlm.nih.gov/26849842/Christopher Lieu, Robert Anderson
https://pubmed.ncbi.nlm.nih.gov/17885392/Zudin A Puthucheary, Jaikitry Rawal, Mark McPhail...
https://pubmed.ncbi.nlm.nih.gov/24108501/Olof Heimbürger, Peter Stenvinkel, Peter Bárány
https://pubmed.ncbi.nlm.nih.gov/23144066/A Sahin Tutak, H Aydin, H A Findikli
https://pubmed.ncbi.nlm.nih.gov/36734702/Charat Thongprayoon, Wisit Cheungpasitporn, Kianoush Kashani
https://pubmed.ncbi.nlm.nih.gov/27162688/Rodrigo Cartin-Ceba, Bekele Afessa, Ognjen Gajic
https://pubmed.ncbi.nlm.nih.gov/17948336/Lydia Williamson, David New
https://pubmed.ncbi.nlm.nih.gov/25239988/University Hospital Ostrava
Lead Sponsor